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Abstract  26 
Staphylococcus aureus is a major mastitis-causing pathogen in dairy cows. The latex 27 
agglutination-based Staphaurex test allows bovine S. aureus strains to be grouped into 28 
Staphaurex
 
latex agglutination test (SLAT)-negative [SLAT(-)] and SLAT-positive 29 
[SLAT(+)] isolates. Virulence and resistance gene profiles within SLAT(-) isolates are highly 30 
similar, but differ largely from those of SLAT(+) isolates. Notably, specific genetic changes 31 
in important virulence factors were detected in SLAT(-) isolates. Based on the molecular data, 32 
it is assumed that SLAT(+) strains are more virulent than SLAT(-) strains. The objective of 33 
this study was to investigate if SLAT(-) and SLAT(+) strains can differentially induce an 34 
immune response with regard to their adhesive capacity to epithelial cells in the mammary 35 
gland and in turn, could play a role in the course of mastitis. Primary bovine mammary 36 
epithelial cells (bMEC) were challenged with suspensions of heat inactivated SLAT(+) (n=3) 37 
and SLAT(-) (n=3) strains isolated from clinical bovine mastitis cases. After 1, 6, and 24 h, 38 
cells were harvested and mRNA expression of inflammatory mediators (TNF-α, IL-1β, IL-8, 39 
RANTES, SAA, lactoferrin, GM-CSF, COX-2, and TLR-2) was evaluated by reverse 40 
transcription and quantitative PCR. Transcription (ΔΔCT) of most measured factors was 41 
induced in challenged bMEC for 6 and 24 h. Interestingly, relative mRNA levels were higher 42 
(P <0.05) in response to SLAT(+) compared to SLAT(-) strains. In addition, adhesion assays 43 
on bMEC also showed significant differences between SLAT(+) and SLAT(-) strains.  44 
The present study clearly shows that these two S. aureus strain types cause a differential 45 
immune response of bMEC and exhibit differences in their adhesion capacity in vitro. This 46 
could reflect differences in the severity of mastitis that the different strain types may induce.  47 
 48 
 49 
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Introduction 50 
Mastitis has a profound impact on dairy production causing considerable economic losses [1], 51 
and affecting animal welfare [2]. Its predominant cause is the invasion of bacteria that enter 52 
the udder via the teat canal [3], [4]. The virulence of the pathogen and the immune response 53 
of the cow determine the clinical outcome of mastitis [5], [6].  54 
According to several in vivo and in vitro studies [7], distinct bacterial species affect the cow’s 55 
immune response differently: E. coli and its cell wall component LPS induce a stronger and 56 
qualitatively different immune reaction in the mammary gland and in bovine mammary 57 
epithelial cells (bMEC) than S. aureus or LTA from S. aureus. Moreover, it was shown that 58 
different strains of a bacterial species have varying effects on the immune response [5], [8], 59 
[9]. 60 
S. aureus belongs to one of the most important etiological agents of bovine mastitis and is 61 
referred to as a major udder pathogen. The Staphaurex latex agglutination test (Remel, Oxoid, 62 
Pratteln, Switzerland) is a diagnostic instrument widely used to confirm putative S. aureus 63 
isolates through detection of characteristic S. aureus surface proteins. Latex particles coated 64 
with human IgG and fibrinogen interact with the bacterial target proteins SpA (staphylococcal 65 
protein A), ClfA/B (clumping factor A/B), and FnbA/B (fibronectin-binding protein A/B), 66 
mediating a rapid agglutination reaction visible to the naked eye. While the Staphaurex latex 67 
agglutination test exhibits high specificity (99.5%) and sensitivity (99.8%) when applied to S. 68 
aureus strains obtained from humans, Stutz et al. [10] reported that 54% of S. aureus isolates 69 
obtained from cases of bovine mastitis yield negative test results. The latex agglutination-70 
negative phenotypes are due to sequence polymorphisms leading to impaired functionality of 71 
one or several of the targeted virulence factors Spa, ClfA/B, and FnbA/B. According to Moser 72 
et al. [11], all Staphaurex latex agglutination test (SLAT)-negative [SLAT(-)] strains belong 73 
to clonal complex (CC) 151, whereas SLAT-positive [SLAT(+)] strains can be assigned to 74 
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various CCs. Furthermore, DNA microarray profiles for virulence and resistance genes were 75 
highly similar among SLAT(-) isolates, but differed largely from those of SLAT(+) isolates. 76 
Based on all this molecular data, it is assumed that SLAT(+) strains exceed SLAT(-) strains in 77 
virulence [11].  78 
The bMEC lining the inner surface of the mammary gland are crucial for the early defense 79 
against intramammary pathogens. They constitute a physical barrier, and they produce, 80 
concomitantly to somatic cells in milk, several antimicrobial substances and inflammatory 81 
mediators that enhance effector functions of innate immunity and stimulate adaptive 82 
immunity [6], [12], [13]. 83 
Pathogens that enter the lumen of the mammary gland are sensed via Toll-like receptors 84 
(TLR) that recognize pathogen-associated molecular patterns (PAMPs) [14]-[16]. Finally, 85 
signaling pathways that eventually activate transcription factors for genes that promote 86 
protective and inflammatory responses are induced. Important factors of the mammary 87 
immune response include the pro-inflammatory cytokines tumor necrosis factor-α (TNF-α) 88 
and interleukin (IL)-1β, known to be expressed in the early immune response of the mammary 89 
gland [1]. They induce other immune factors like granulocyte-macrophage colony stimulating 90 
factor (GM-CSF) which mediates differentiation of hematopoietic progenitors into 91 
granulocytes and monocytes [17]. Chemokines such as IL-8 and RANTES (Regulated and on 92 
activation, normal T cell expressed and secreted) attract leukocytes from the blood to the site 93 
of infection, which is reflected by an increase of somatic cell count (SCC) in milk [1]. 94 
Furthermore, antibacterial proteins including lactoferrin (Lf) and serum amyloid A (SAA), as 95 
well as cyclooxygenase-2 (COX-2), an enzyme involved in the prostaglandin synthesis, are 96 
secreted by bMEC [12], [18], [19].  97 
 98 
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As it is assumed that SLAT(+) are more virulent than SLAT(-) and the immune response of 99 
the mammary gland to bacteria of different virulence is diverse, the aim of the present study 100 
was to compare the immune response of bMEC and their adhesion capacity to different S. 101 
aureus strains, belonging either to the SLAT(+) or SLAT(-) group.  102 
According to the current study, there is clear evidence that the SLAT phenotype affects the 103 
immune response of bMEC and the adhesion capacity in vitro.  104 
 105 
 106 
Materials and Methods 107 
S. aureus strains 108 
The six S. aureus strains (Table 1) used in this study were isolated from bovine mastitis milk 109 
samples collected from different cows [11]. The milk samples from mastitis were collected 110 
after the diagnosis of acute mastitis by the attending veterinarian, including a positive result of 111 
the California Mastitis Test. Bacterial cultures were maintained in peptone with 20% glycerol 112 
at -70°C. Prior to experiments, isolates were grown overnight on tryptic soy agar (TSA; 113 
Difco, Becton Dickinson Diagnostics, Mississauga, ON, Canada) at 37°C. Individual S. 114 
aureus strains were then inoculated in 10 ml cultures of brain heart infusion (BHI; Oxoid, 115 
Pratteln, Switzerland) broth and grown overnight at 37°C. Colony counts were determined for 116 
each strain (~10
9
 CFU/ml).  117 
 118 
Treatment of bMEC with different S. aureus strains 119 
Primary cultures of mammary gland epithelial cells of two Holstein dairy cows with clinically 120 
healthy udders (SCC <10
5 
cells/ml) were developed as previously described [20]. Mammary 121 
tissue was removed directly after slaughter with permission of the slaughterhouse Marmy SA, 122 
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Estavayer-le-Lac, Switzerland. Cells in passage 2 were cryopreserved in DMEM/F12 (Sigma-123 
Aldrich, Munich, Germany) containing 20% fetal bovine serum (FBS, Sigma-Aldrich) and 124 
10% dimethyl sulfoxide (DMSO, Sigma-Aldrich) and stored in aliquots at –80°C until the 125 
experiment. Cells from both cows were thawed and cultured in growth medium consisting of 126 
DMEM/F12 supplemented with 10% FBS, penicillin G (500 units, Sigma-Aldrich), 127 
streptomycin (100 µg/ml, Sigma-Aldrich), and ITS (0.5 mg/ml insulin, 0.5 mg/ml apo-128 
transferrin, 0.5 µg/ml sodium selenite; Sigma-Aldrich). After two further passages, cells were 129 
seeded at a concentration of 3 x 10
5
 cells/well on BD Falcon™ 6-well cell culture plates (BD 130 
Biosciences, San Jose, CA, USA). On the following day, growth medium was replaced by 131 
DMEM/F12 supplemented with 5% FBS and ITS. 132 
Suspensions of heat inactivated bacteria (inactivated by heating for 20 min at 80°C) were 133 
diluted to a concentration of 1 x 10
9
 CFU/ml in BHI broth. The cells were challenged in 134 
triplicate with 150 µl of the bacterial suspension. Assuming that 3 x 10
5
 cells/well after 24 h 135 
of incubation and a confluence of about 70% represent approximately 1 x 10
6
 cells/well, this 136 
corresponds to a multiplicity of infection (MOI) of 150. As a positive control, cells were 137 
challenged with 150 MOI of Escherichia coli in duplicate. Cells incubated in DMEM/F12, 138 
5% FBS, and ITS only served as negative controls. Cells were incubated at 37°C with 5% 139 
CO2. 140 
 141 
Total RNA extraction and reverse transcription 142 
After 1, 6, or 24 h of incubation, cells were harvested with 0.5 ml peqGOLD Trifast™ 143 
(PEQLAB Biotechnologie GmbH, Erlangen, Germany) and total RNA was extracted 144 
according to the manufacturer’s protocol. Total RNA yield and purity were determined by 145 
absorbance at 260 nm and 280 nm using a NanoDrop-2000 spectrophotometer (Thermo 146 
Fisher Scientific Inc., Waltham, MA, USA). Finally, 500 ng of total RNA was reverse 147 
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transcribed by 200 units of Moloney Murine Leukemia Virus Reverse Transcriptase (M-MLV 148 
RT; Promega Corp., Madison, WI, USA) using 100 pmol of random hexamer primers 149 
(Invitrogen, Leek, The Netherlands).  150 
  151 
Quantitative real-time PCR 152 
Quantitative real-time PCR analysis was performed with the Sensimix DNA Kit (Quantace, 153 
Biolabo, Châtel St. Denis, Switzerland) on a Rotor-Gene 6000 (Corbett Research, Sydney, 154 
Australia). One reaction mixture contained 2 µl of cDNA equivalent to 25 ng of total RNA, 155 
0.8 µl RNase-free water (Qiagen, Hilden, Germany), 1 µl (5 pmol) of forward primer, 1 µl (5 156 
pmol) of reverse primer, and 5.2 µl of 2x SensiMix plus SYBR-Green (1 mM MgCl2). 157 
Primers for the housekeeping (GAPDH and ubiquitin) and target genes were synthesized 158 
commercially (Microsynth, Balgach, Switzerland) using previously published sequences [12], 159 
[18], [21], [22], or designed using the open source primer design software Primer 3 (primer 160 
sequences are listed in Table 2).  161 
The following 3-step PCR program was used: initial denaturation for 10 min at 95°C, 162 
followed by 40 cycles with denaturation for 15 s at 95°C, 30 s at primer-specific annealing 163 
temperature, and elongation for 20 s at 72°C. Fluorescence was acquired at 72°C after each 164 
cycle, and a dissociation melt curve of the PCR product was determined at the end of each run 165 
to verify the specificity of the PCR reactions. 166 
Cycle threshold (Ct) values were determined by the Rotor-Gene software version 1.7.75, and 167 
the relative mRNA expression was calculated with the comparative Ct method [23] using the 168 
following equation:  169 
ΔCt = Ct target gene – Ct endogenous control (arithmetic mean of housekeeping genes). 170 
To visualize the impact of SLAT(+) and SLAT(-) strains on the immune response of bMEC, 171 
data are presented as ΔΔCt ± SEM, where: 172 
8 
 
ΔΔCt = ΔCt sample (1, 6, or 24 h; treated) – ΔCt negative control (1, 6, or 24 h; untreated). 173 
 174 
Adhesion Assay 175 
The adhesion assay was performed as previously described [24]. Bovine mammary epithelial 176 
cells derived from the same cows mentioned above were grown on sterile plastic coverslips 177 
(13 mm diameter, Bibby Sterilin, Stone, UK) coated with rat tail collagen (BD Biosciences, 178 
Allschwil, Switzerland). The bMEC on coverslips were cultured at 37°C for 24 h in 24-well 179 
plates (24-well flat-bottom cell culture plate with Low-Evaporation Lid, TPP, Trasadingen, 180 
Switzerland) until they reached a confluency of 70-80%. Suspensions of live bacteria were 181 
used at a concentration of 150 MOI to infect coverslips in duplicate. Infected bMEC cells of 182 
both cows were incubated for 3 h at 37°C. Uninfected bMECs were incubated in parallel and 183 
used as negative controls. After 3 h post infection, cell monolayers were washed five times 184 
with Dulbecco's phosphate buffered saline (DPBS) (GIBCO, Invitrogen, Carlsbad, CA, USA) 185 
and fixed with absolute methanol (-20°C) for 10 min. After the staining with May-Grünwald-186 
Giemsa (Fluka, Buchs SG, Switzerland), the coverslips were examined by oil immersion light 187 
microscopy at a magnification of 1000x. 188 
Adhesion affinity of the SLAT(+) and SLAT(-) S. aureus strains on bMEC was assessed by 189 
counting of 200 cells per coverslip and the presence of adhered bacteria. Each cell with at 190 
least one firmly adhered bacterium was counted as positive. Mean percentage of positive cells 191 
were compared between the three SLAT(+) and the three SLAT(-) S. aureus strains, 192 
respectively.  193 
 194 
Statistical Analysis 195 
Data are presented as means ± SEM. Statistical analysis of the inflammatory response data 196 
was performed with ANOVA using a MIXED procedure of SAS (Release 9.2; SAS Institute 197 
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Inc., Cary, NC, USA). The model included strain, type, and their interaction as fixed effects. 198 
Results of the triplicates were nested within cow. Statistical analysis of the adhesion 199 
experiments was performed using an unpaired t-test. Differences were considered significant 200 
if P <0.05. 201 
 202 
 203 
Results 204 
Relative mRNA expression of immune factors 205 
Cells challenged with E. coli (positive control) induced an increase in mRNA expression of 206 
IL-1β, TNF-α, IL-8, and GM-CSF after 1 h of stimulation. Furthermore, E. coli induced 207 
mRNA expression of all factors after 6 and 24 h of stimulation (data not shown). 208 
Cells challenged with S. aureus for only 1 h had no significant effect on the relative mRNA 209 
expression of all measured factors in bMEC, with the exception of IL-1β and IL-8. IL-1β 210 
mRNA expression was significantly upregulated in response to most of the tested S. aureus 211 
strains, regardless of SLAT phenotype. IL-8 mRNA expression was significantly induced in 212 
bMEC challenged for 1 h with SLAT(+) strains (Table 3).  213 
The relative mRNA expression of IL-1β, TNF-α, and IL-8 was significantly increased after 6 214 
and 24 h in response to all S. aureus strains, except for IL-1β mRNA expression after 215 
challenge with SLAT(-) strain 1586 for 24 h. After 24 h of challenge, mRNA levels of IL-1β, 216 
TNF-α, and IL-8 were equal or lower than after 6 h (Table 3). 217 
All SLAT(+) strains induced increased mRNA levels of RANTES in bMEC challenged for 6 218 
or 24 h. Within the SLAT(-) group, only strain 1904 induced elevated mRNA levels after 6 219 
and 24 h of challenge. For all strains, similar RANTES mRNA levels were obtained in cells 220 
challenged for either 6 or 24 h (Table 3). For IL-1β, TNF-α, IL-8, and RANTES the relative 221 
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mRNA abundances were significantly higher in cells challenged for 6 and 24 h with SLAT(+) 222 
than with SLAT(-) strains (Table 4, Figure 1).  223 
Lactoferrin and SAA were upregulated in bMEC challenged for 6 and 24 h with SLAT(+) 224 
strains, whereas the increase was equal or higher after 24 h (Table 3). Two of the SLAT(-) 225 
strains increased SAA mRNA expression after 6 and 24 h of stimulation (Table 3). 226 
Lactoferrin mRNA expression was significantly increased after 24 h of stimulation in 227 
response to all SLAT(-) strains, whereas after 6 h only one of the SLAT(-) strains induced Lf 228 
transcription (Table 3). SLAT(+) significantly induced higher relative mRNA levels of SAA 229 
and Lf than SLAT(-) strains (Table 4, Figure 1). 230 
In response to all SLAT(+) strains, GM-CSF mRNA expression was significantly increased 231 
after 6 h of challenge, but decreased again between 6 and 24 h. The challenge of bMEC with 232 
SLAT(+) for 6 h caused significantly higher GM-CSF mRNA expression compared to 233 
SLAT(-) strains (Tables 3 & 4). Two SLAT(-) strains affected GM-CSF mRNA expression in 234 
bMEC stimulated for 6 h (Table 3).  235 
Expression levels of COX-2 mRNA were affected after stimulation for 6 h with all SLAT(+), 236 
as well as with one SLAT(-) strain (Table 3). Although the SLAT(+)-induced response was 237 
significantly stronger after 6 h for COX-2 compared to SLAT(-) (Table 4), individual strain 238 
differences were not consistently significant between both groups (Table 3). 239 
In response to all S. aureus strains, except for SLAT(-) 1586, relative mRNA levels of TLR2 240 
were significantly increased in bMEC stimulated for 6 and 24 h. The mRNA levels were 241 
similar in bMEC stimulated for 6 or 24 h (Table 3). After 6 and 24 h, the expression of TLR2 242 
mRNA was more pronounced in bMEC stimulated with SLAT(+) than with the SLAT(-) type 243 
(Table 4).  244 
Although SLAT(+) significantly induced higher mRNA expression levels than SLAT(-) for 245 
all measured factors (Table 4), mRNA expression differed between individual strains for most 246 
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time points (Table 3). In addition, there were significant strain by cow interactions in half of 247 
the measurements, and the cells from differing cows had a significant impact on mRNA 248 
expression of all factors at most time points (Table 3). A similar expression pattern of most 249 
immune factors was seen in SLAT(+) and E. coli challenged bMEC after 6 and 24 h (data not 250 
shown). 251 
 252 
Adhesion Assay 253 
After 3 h post infection, bMEC were morphologically unaltered irrespective of the S. aureus 254 
strain and when compared to the negative controls (confluency of 70-80%). All six S. aureus 255 
strains showed a variable degree of adhesion (10-55%) to bMEC. Clusters of more than 20 256 
adherent bacteria were frequently observed in SLAT(+) but not in SLAT(-) S. aureus strains. 257 
There was a statistically significant difference in adhesion affinity between the SLAT(+) and 258 
SLAT(-) S. aureus strains in cells of both cows (Table 5).  259 
 260 
 261 
Discussion 262 
Cultured primary bMEC responded to the challenge with heat inactivated bacteria by 263 
upregulation of genes relevant in the immune reaction of the mammary gland. This was 264 
highly reproducible and verifies the suitability of the model for comparison of the innate 265 
immune response to different bacterial strains. By using cells from two different cows, the 266 
biological reproducibility was proven. With some exceptions, the factor ‘cow’ had a 267 
significant effect on the results. Differences are most likely attributed to the genotype of the 268 
cows, as it was shown that bMEC from cows with genetic differences in mastitis 269 
susceptibility can show a difference in magnitude of transcription of immune factors in 270 
response to bacterial challenge [25].  271 
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Escherichia coli was chosen as a positive control as it often causes acute mastitis. Heat 272 
inactivated E. coli isolated from acute mastitis cases induced a strong immune response 273 
characterized by highly induced mRNA expression of important immune factors in mammary 274 
epithelial cells in culture [12]. This is in agreement with the present study, as the mRNA 275 
expression for all measured factors was strongly upregulated after at least 6 h post challenge.  276 
Three different periods of challenge were used in the present study to capture the change of 277 
different immune factors that are expressed in the early and later phases of the immune 278 
response. Griesbeck-Zilch et al. [12] found that mRNA levels of IL-1β, TNF-α, and IL-8 were 279 
already increased in bMEC after 1 h of challenge with the heat inactivated S. aureus strain 280 
M60. Comparable results were seen in the present study with several S. aureus strains, which 281 
indicates that bMEC respond directly to contact with heat inactivated S. aureus, regardless of 282 
the bacterial type, i.e. SLAT(+) or SLAT(-). Interestingly for IL-8, a stronger increase of 283 
transcription was detectable after 1 h of challenge for SLAT(+) strains compared to SLAT(-) 284 
strains. It is apparent for the other factors that 1 h of challenge was not long enough to induce 285 
measurable changes in transcription of the selected factors. However, after challenging the 286 
cells for a longer period of time, the induction of mRNA expression of all measured immune 287 
factors was more pronounced by SLAT(+) compared to SLAT(-) strains. 288 
In clinical mastitis caused by S. aureus, IL-1β and TNF-α are expressed in the early stages of 289 
the infection period, soon followed by a considerable decrease [4], [26]. It is assumed that the 290 
duration of enhanced transcription of these pro-inflammatory cytokines is not sufficient to 291 
eliminate S. aureus from the mammary gland, and therefore may often lead to a chronic 292 
outcome [1]. In contrast, E. coli typically causes a more sustained increase of these cytokines 293 
[4]. E. coli intramammary infections are often characterized by acute and severe clinical 294 
manifestations, but can, if not leading to death, be cured within a few days [1], [27]. 295 
According to the review by Oviedo-Boyso et al. [1], in the present study, S. aureus-induced 296 
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mRNA expression of IL-1β and TNF-α was increased at least after 6 h of stimulation and 297 
decreased again until 24 h post challenge. The observation that SLAT(+) and SLAT(-) strains 298 
induced a different expression of these pro-inflammatory cytokines in bMEC may indicate 299 
that these strains induce different severities of mastitis. However, the severity of mastitis that 300 
these strains induced is not known. 301 
The stronger induction of the mRNA expression pattern of the chemokines IL-8 and RANTES 302 
in bMEC may suggest earlier and stronger leukocyte recruitment during the innate immune 303 
response after an intramammary infection with SLAT(+) compared to infections with SLAT(-304 
) strains. The immediate recruitment of somatic cells from the blood into the udder is essential 305 
for effective elimination of intramammary pathogens [28]. Thus, a deviating time point and 306 
magnitude of leukocyte recruitment, which is reflected in the chemokine expression, might 307 
influence the clinical course of mastitis. Since no clinical data including somatic cell count 308 
were available for the tested S. aureus strains in the present study, conclusions cannot be 309 
drawn on the clinical manifestation of the infection.  310 
The acute phase protein SAA is known to be expressed in bMEC and is upregulated during 311 
mastitis [29]. Wellnitz et al. [21] reported similarly increased mRNA levels of SAA in cells 312 
challenged for 6 h with S. aureus or E. coli. In the present study, SLAT(+) induced a stronger 313 
SAA mRNA expression compared to SLAT(-) S. aureus strains. However, mRNA levels 314 
induced by E. coli were equal or higher during the whole study than in response to S. aureus, 315 
depending on the SLAT type. As SAA is also a chemoattractant [30], [31], pathogens that 316 
upregulate SAA transcription could be associated with an increase of SCC in the mammary 317 
gland. This effect could, as described for IL-8 above, have an effect on the progress of the 318 
mastitis. 319 
Epithelial cells from the mammary gland are the major source of the iron-binding protein Lf 320 
that increases in milk during bovine clinical mastitis [28]. Griesbeck-Zilch et al. [12] showed 321 
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a more pronounced Lf mRNA expression in bMEC by S. aureus than by E. coli challenge. In 322 
the present study, E. coli induced comparable Lf mRNA levels to SLAT(+) but higher levels 323 
compared to SLAT(-). However, neither the SLAT phenotype of S. aureus strains, nor details 324 
on the E. coli strain used in the study of Griesbeck-Zilch et al. [12] are known, which could 325 
account for a deviating Lf expression pattern in bMEC. Comparing the Lf mRNA expression 326 
between S. aureus strains in the present study clearly shows that SLAT(+) strains induced 327 
higher levels than SLAT(-), which again confirms a deviating immune response of the 328 
mammary gland to SLAT(+) and SLAT(-) strains. Only SLAT(-) strain 1904 caused Lf 329 
mRNA levels that were not significantly lower than in response to two of the SLAT(+) 330 
strains. Thus, the induction of Lf mRNA expression in bMEC might follow different strain-331 
dependent mechanisms. 332 
Another cytokine that was stronger induced on the mRNA level by SLAT(+) compared to 333 
SLAT(-) S. aureus strains in bMEC is GM-CSF. Since GM-CSF is responsible for an 334 
appropriate supply of leukocytes, the effector cells of the innate immune system, it is likely 335 
that high levels of GM-CSF expression represent a strong inflammatory response in the 336 
mammary gland. As a consequence, it is possible that SLAT(+) cause more severe forms of 337 
mastitis.  338 
The transient upregulation of GM-CSF in response to all SLAT(+), as well as to the majority 339 
of SLAT(-) strains indicates that the role of bMEC in stimulating phagocyte differentiation is 340 
rather short term. This is consistent with an in vivo study, where mRNA expression of 341 
somatic cells upon S. aureus infection was evaluated [32].  342 
The observation that TLR2 mRNA, a receptor for cell wall components of gram-positive 343 
bacteria, was induced in response of the majority of the S. aureus strains, confirms the 344 
involvement of this pattern recognition receptor (PRR) [12]. SLAT(+) S. aureus strains 345 
showed a stronger induction of TLR2 mRNA than SLAT(-) strains. Interestingly, one strain, 346 
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SLAT(-) 1586, apparently did not induce TLR2 mRNA expression in bMEC. One possible 347 
reason could be that this strain has an altered PAMP, i.e. LTA or peptidoglycan that is 348 
normally recognized by this PRR. To confirm this, further investigations are necessary. Even 349 
though most studies describe TLR2 as a primary receptor for gram-positive bacteria, it is also 350 
known that this PPR is responsive to gram-negative bacteria [33]. This point also explains the 351 
induced TLR2 expression by E. coli. 352 
Prostaglandins are further inflammatory mediators in the bovine mammary gland with 353 
chemotactic activity [34]. COX-2 is one of the enzymes involved in prostaglandin synthesis 354 
that is transiently upregulated during inflammation [35], [36]. These findings are reflected by 355 
this study. COX-2 was only transiently upregulated in bMEC in response to all S. aureus 356 
strains, except to one SLAT(-) strain. Compared to the other measured immune factors, the 357 
SLAT(+) group is not as strong of an inducer of COX-2 and TLR2 compared to SLAT(-), 358 
since differences were not consistently significant between the SLAT groups.  359 
 360 
 361 
Conclusion  362 
The results of this study clearly indicate a different immunological response of bMEC to 363 
SLAT(+) and SLAT(-) strains. Although individual differences within SLAT groups and the 364 
cow seem to influence the immune response, SLAT(+) S. aureus strains induce a more 365 
pronounced transcription of several important immune factors compared to SLAT(-) strains in 366 
mammary epithelial cells. Furthermore, results obtained from adhesion assays indicate that 367 
SLAT(+) S. aureus strains show an increased affinity to adhere to bMEC than SLAT(-) 368 
strains. These findings together with molecular data on the S. aureus strains might support the 369 
hypothesis that SLAT(+) exceed SLAT(-) strains in virulence. The influence of these effects 370 
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on the varying course and severity of mastitis can be suggested and should be further 371 
investigated in vivo. 372 
 373 
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 483 
Figure legends 484 
Figure 1 (A-F). Relative SAA and TNF-α mRNA expression. 485 
Relative mRNA expression (ΔΔCt) of SAA in bMEC stimulated for (A) 1 h, (B) 6 h, or (C) 486 
24 h with SLAT(+), SLAT(-), or E. coli. Relative mRNA expression (ΔΔCt) of TNF-α in 487 
bMEC stimulated for (D) 1 h, (E) 6 h, or (F) 24 h with SLAT(+), SLAT(-) or E. coli. Data are 488 
presented as Means ± SEM. a,bMeans without common superscript letters differ (P<0.05). 489 
490 
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Table 1. S. aureus strains used in this study  491 
strain Clonal complex Staphaurex test 
phenotype 
Anamestic data 
692 CC8 positive acute  mastitis 
1130 CC97 positive acute  mastitis 
1989 CC20 positive acute  mastitis 
1586 CC705 negative acute  mastitis 
1904 CC705 negative acute  mastitis 
2071 CC705 negative acute  mastitis 
Reference: [11] 492 
493 
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Table 2. Sequences, accession numbers, annealing temperature of the PCR primers, and 494 
length of the PCR products 495 
Gene1 Sequence 5’→3’ 
GenBank accession 
no. 
Annealing 
temperature 
(°C) 
Length 
(bp) 
IL-1β for AGT GCC TAC GCA CAT GTC TTC2 M37211 60 114 
 rev TGC GTC ACA CAG AAA CTC GTC2    
TNF-α for CCA CGT TGT AGC CGA CAT C2 NM173966 60 155 
 rev CCC TGA AGA GGA CCT GTG AG2    
IL-8 for ATG ACT TCC AAG CTG GCT GTT G2 AF232704 60 149 
 rev TTG ATA AAT TTG GGG TGG AAA G2    
RANTES for GCC AAC CCA GAG AAG AAG TG2 BC102064 60 119 
 rev CTG CTT AGG ACA AGA GCG AGA2    
SAA for CCT GGG CTG CTA AAG TGA TC3 AF540564 57 184 
 rev TAC TTG TCA GGC AGG CCA G3    
Lf for GGC CTT TGC CTT GGA ATG TAT4 L08604 62 338 
 rev ATT TAG CCA CAG CTC CCT GGA G4    
GM-CSF for TTC TCC GCA CCT ACT CGC NM174027 62 195 
 rev GTT CTT GTA CAG CTT CAG GCG    
COX-2 for TCC TGA AAC CCA CTC CCA ACA5 NM174445 62 242 
 rev TGG GCA GTC ATC AGG CAC AG5    
TLR2 for CAT TCC CTG GCA AGT GGA TTA TC2 NM174197 62 201 
 rev GGA ATG GCC TTC TTG TCA ATG G2    
GAPDH for GTC TTC ACT ACC ATG GAG AAG G2 NM001034034 60 197 
 rev TCA TGG ATG ACC TTG GCC AG2    
Ubiquitin for AGA TCC AGG ATA AGG AAG GCA T2 NM174133 62 198 
 rev GCT CCA CCT CCA GGG TGA T2    
for = forward, rev = reverse 496 
1IL-1β = interleukin-1β; TNF-α = tumor necrosis factor-α; IL-8 = interleukin-8; RANTES = regulated on activation, normal 497 
T cell expressed and secreted; SAA = serum amyloid A; Lf = lactoferrin; GM-CSF = granulocyte-macrophage colony-498 
stimulating factor; COX-2 = cyclooxygenase-2; TLR2 = toll-like receptor 2; GAPDH = glyceraldehyde-3-phosphate 499 
dehydrogenase 500 
Primer sequence references : 2[12]; 3[21], 4[18], 5[22]501 
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Table 3. Changes of mRNA abundance (Mean ± SEM ΔΔCt1) of immune factors in bMEC 502 
stimulated with six heat-inactivated S. aureus strains for 1, 6, or 24 h 503 
 504 
  SLAT(+)
3 SLAT(-)3 Analysis of variance (P-value) 
Gene2 Time (h) 692 1130 1989 1586 1904 2071 Strain(Type) Cow Strain*Cow 
IL-1β 1 0.5 ± 0.3 ac 1.6 ± 0.2 b * 1.3 ± 0.3 bc * 1.3 ± 0.5 bc * 1.5 ± 0.4 b * 0.5 ± 0.3 a 0.01 <0.01 0.03 
 6 8.3 ± 0.2 a * 8.7 ± 0.2 a * 8.3 ± 0.3 a * 3.5 ± 0.1 b * 5.7 ± 0.5 c * 5.3 ± 0.2 c * <0.01 <0.01 0.01 
 24 5.1 ± 0.3 ab * 5.7 ± 0.2 b * 4.8 ± 0.1 a * 0.4 ± 0.4 c 1.8 ± 0.3 d * 1.6 ± 0.3 d * <0.01 <0.01 0.03 
TNF-α 1 0.7 ± 0.2 
a 0.8 ± 0.1 a 0.3 ± 0.3 a 0.2 ± 0.6 ab 05 ± 0.5 a -0.6 ± 0.3 b 0.07 <0.01 0.02 
 6 5.4 ± 0.4 a * 5.1 ± 0.2 a * 5.1 ± 0.4 a * 1.3 ± 0.6 b * 3.4 ± 0.3 c * 2.9 ± 0.4 c * <0.01 <0.01 0.75 
 24 4.1 ± 0.2 a * 4.3 ± 0.2 a * 4.1 ± 0.1 a * 1.1 ± 0.2 b * 2.0 ± 0.4 c * 1.6 ± 0.1 bc * 0.11 0.06 0.23 
IL-8 1 2.0 ± 0.5 a * 2.1 ± 0.4 a * 1.5 ± 0.2 ab * 0.6 ± 0.4 b 0.8 ± 0.3 b 0.9 ± 0.5 b 0.73 <0.01 0.07 
 6 7.8 ± 0.2 a * 7.1 ± 0.2 b * 7.0 ± 0.4 b * 4.7 ± 0.1 c * 6.1 ± 0.3 d * 5.4 ± 0.3 e * <0.01 <0.01 0.01 
 24 7.1 ± 0.3 
a * 7.0 ± 0.2 a * 7.1 ± 0.1 a * 3.5 ± 0.4 b * 4.8 ± 0.2 c * 4.1 ± 0.6 c * <0.01 <0.01 0.01 
RANTES 1 -0.2 ± 0.2 
ab -0.6 ± 0.3 ab 0.1 ± 0.5 a -0.6 ± 0.4 ab -0.5 ± 0.4 ab -0.8 ± 0.5 b 0.56 <0.01 0.72 
 6 3.9 ± 0.2 
a * 4.3 ± 0.2 a * 2.9 ± 0.3 b * 0.0 ± 0.2 c 1.8 ± 0.4 d * 1.0 ± 0.3 e * <0.01 <0.01 0.69 
 24 3.2 ± 0.3 
a * 4.0 ± 0.3 b * 3.0 ± 0.3 a * -0.1 ± 0.5 c 1.1 ± 0.2 d * 0.6 ± 0.4 d <0.01 <0.01 0.06 
SAA 1 -1.0 ± 0.5 a -0.6 ± 0.4 ab 0.8 ± 1.0 c -0.9 ± 0.9 a 0.7 ± 0.8 bc -0.9 ± 0.6 a 0.01 <0.01 0.50 
 6 5.6 ± 0.6 a * 4.9 ± 0.5 ab * 4.7 ± 0.4 b * 0.8 ± 0.4 c 3.6 ± 0.3 d * 1.6 ± 0.3 e * <0.01 <0.01 <0.01 
 24 5.3 ± 0.4 a * 5.3 ± 0.6 a * 6.3 ± 0.5 b * 1.9 ± 0.5 c * 3.3 ± 0.4 d * 3.0 ± 0.6 d * <0.01 <0.01 0.47 
Lf 1 0.7 ± 0.2 a 0.1 ± 0.3 bc -0.1± 0.2 d 0.4 ± 0.4 ab -0.7 ± 0.4 d -0.6 ± 0.3 cd 0.01 <0.01 0.53 
 6 2.6 ± 0.4 a * 2.1 ± 0.1 ab *  1.9 ± 0.4 b * 0.0 ± 0.5 c 1.6 ± 0.2 b * 0.6 ± 0.2 d <0.01 <0.01 0.02 
 24 3.9 ± 0.5 a * 3.6 ± 0.5 a * 4.1 ± 0.5 a * 1.9 ± 0.8 b * 2.4 ± 0.4 b * 1.6 ± 0.7 b * 0.36 <0.01 0.03 
GM-CSF 1 0.6 ± 0.2 
a 0.0 ± 0.4 ab -0.5 ± 0.5 b 0.3 ± 0.1 a 0.4 ± 0.2 a 0.5 ± 0.3 a 0.07 0.01 0.16 
 6 3.1 ± 0.1 a * 3.9 ± 0.2 b * 3.0 ± 0.4 a * 0.0 ± 0.3 c 1.6 ± 0.2 d * 1.9 ± 0.3 d * <0.01 0.71 0.04 
 24 0.4 ± 0.6 
ab 1.7 ± 0.4 c * 0.5 ± 0.4 a -1.4 ± 0.3 d -0.7 ± 0.4 bd -1.0 ± 0.6 d 0.06 <0.01 0.39 
COX-2 1 0.5 ± 0.3 0.3 ± 0.2  -0.1 ± 0.4  0.6 ±0.3  -0.3 ± 0.5  0.0 ± 0.1  0.27 0.08 0.03 
 6 1.8 ± 0.2 a * 1.8 ± 0.4 ab * 1.5 ± 0.3 abd * 0.2 ±0.1 c 1.1 ± 0.1 bd * 1.0 ± 0.4 d 0.06 <0.01 0.01 
 24 0.1 ± 0.5 ab 0.8 ± 0.2 b 0.8 ± 0.2 b -0.6 ±0.3 a -0.3 ± 0.2 a -0.4 ± 0.4 a 0.58 0.59 <0.01 
TLR2 1 0.0 ± 0.3 a 0.6 ± 0.3 a 0.3 ± 0.9 a 0.6 ±0.3 a -0.3 ± 0.3 a -0.2 ± 0.5 a 0.57 0.05 0.95 
 6 2.7 ± 0.3 a *  1.9 ± 0.2 b * 2.0 ± 0.3 b * 0.4 ±0.4 c 1.7 ± 0.2 bd * 1.1 ± 0.3 d * <0.01 <0.01 <0.01 
 24 2.1 ± 0.4 ab * 2.2 ± 0.6 a * 2.6 ± 0.5 a * 0.9 ±0.4 c 1.5 ± 0.3 bc * 1.1 ± 0.6 c * 0.23 <0.01 0.51 
a- eMeans within a row without common superscript letters differ (P<0.05) 505 
*Means differ significantly from negative control 506 
1ΔΔCt values are normalized to negative controls and corrected for the two reference genes, GAPDH and ubiquitin 507 
2IL-1β = interleukin-1β; TNF-α = tumor necrosis factor-α; IL-8 = interleukin-8; RANTES = regulated on activation, normal 508 
T cell expressed and secreted; SAA = serum amyloid A; Lf = lactoferrin; GM-CSF = granulocyte-macrophage colony-509 
stimulating factor; COX-2 = cyclooxygenase-2; TLR2 = toll-like receptor 2 510 
3SLAT(-) = S. aureus latex agglutination test negative; SLAT(+) = S. aureus latex agglutination test positive 511 
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Table 4. Effect of SLAT type on changes of mRNA expression (Mean ± SEM ΔΔCt1) of 512 
immune factors in bMEC stimulated for 1, 6, or 24 h  513 
  
Type3 Analysis of variance (P-value) 
Gene2 Time (h) SLAT(+) SLAT(-) Type Cow 
IL-1β 1 1.1 ± 0.2 a* 1.1 ± 0.2 a* 0.87 0.01 
 
6 8.4 ± 0.1 a* 4.8 ± 0.3 b* <0.01 0.03 
 
24 5.2 ± 0.1 a* 1.3 ± 0.2 b* <0.01 <0.01 
TNF-α 1 0.6 ± 0.1 a 0.0 ± 0.3 b 0.03 <0.01 
 6 5.2 ± 0.2 a* 2.5 ± 0.3 b* <0.01 0.02 
 24 4.2 ± 0.1 a* 1.6 ± 0.2 b* <0.01 0.08 
IL-8 1 1.9 ± 0.2 a* 0.8 ± 0.2 b <0.01 <0.01 
 6 7.3 ± 0.2 a* 5.2 ± 0.2 b* <0.01 <0.01 
 24 7.1 ± 0.1 a* 4.1 ± 0.3 b* <0.01 <0.01 
RANTES 1 -0.2 ± 0.2 a -0.7 ± 0.2 a 0.09 <0.01 
 6 3.7 ± 0.2 a* 0.9 ± 0.2 b <0.01 0.04 
 24 3.4 ± 0.2 a* 0.6 ± 0.2 b <0.01 <0.01 
SAA 1 -0.2 ± 0.4 a -0.4 ± 0.5 a 0.52 <0.01 
 6 5.1 ± 0.3 a* 2.0 ± 0.3 b* <0.01 <0.01 
 24 5.6 ± 0.3 a* 2.7 ± 0.3 b* <0.01 <0.01 
Lf 1 0.2 ± 0.2 a -0.3 ± 0.2 b 0.05 <0.01 
 6 2.2 ± 0.2 a* 0.7 ± 0.2 b* <0.01 <0.01 
 24 3.9 ± 0.3 a* 2.0 ± 0.4 b* <0.01 <0.01 
GM-CSF 1 0.0 ± 0.2 a 0.4 ± 0.1 a 0.09 0.01 
 6 3.3 ± 0.2 a* 1.2 ± 0.2 b <0.01 0.79 
 24 0.9 ± 0.3 a -1.0 ± 0.3 b <0.01 <0.01 
COX-2 1 0.2 ± 0.2 a 0.1 ± 0.2 a 0.67 0.08 
 
6 1.7 ± 0.2 a* 0.7 ± 0.2 b <0.01 0.01 
 
24 0.6 ± 0.2 a -0.4 ± 0.2 b <0.01 0.58 
TLR2 1 0.3 ± 0.3 a 0.0 ± 0.2 a 0.45 0.04 
 
6 2.2 ± 0.2 a* 1.1 ± 0.2 b <0.01 0.01 
 
24 2.3 ± 0.3 a* 1.2 ± 0.3 b* <0.01 <0.01 
a-eMeans within a row without common superscript letters differ (P<0.05) 514 
*Means differ significantly from negative control 515 
1ΔΔCt values are normalized to negative controls and corrected for the two reference genes, GAPDH and ubiquitin 516 
2IL-1β = interleukin-1; TNF-α = tumor necrosis factor-α; IL-8 = interleukin-8; RANTES = regulated on activation, normal T 517 
cell expressed and secreted; SAA = serum amyloid A; Lf = lactoferrin; GM-CSF = granulocyte-macrophage colony-518 
stimulating factor; COX-2 = cyclooxygenase-2; TLR2 = toll-like receptor 2 519 
3SLAT(-) = S. aureus latex agglutination test negative; SLAT(+) = S. aureus latex agglutination test positive 520 
521 
25 
 
Table 5. Degree of adhesion (%) of SLAT(+) and SLAT(-) strains to bMEC 522 
bMEC SLAT(+) SLAT(-) 
cow 1 36.1±6.1 
a
 20.6±2.8 
b
 
cow 2 36.1±6.1 
a
 21.0±3.6 
b
 
total (cow 1 & 2) 36.3±4.9 
a
 20.8±3.1 
b
 
a,b Means within a row without common superscript letters differ (P<0.05) 523 
 524 
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